2025 fourth_quarter Filing
Q4Income
$50K
Filed
January 20, 2026
Lobbying Activities
Medicare/MedicaidView all
Issues related to plasma based therapies. H.R. 1476 / S. 694, Preserving Life-saving Access to Specialty Medicines in America (PLASMA) Act. Issues related to gene therapies. Issues related to value-based payments. Issues related to drug shortages. Monitored implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to plasma derived products and drug pricing. Issues related to pharmacy benefit management. Issues related to Most Favored Nation drug pricing.
Contacted:Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
Health IssuesView all
Monitored issues related to medical supply chain and pharmacy benefit management. Monitored issues related to drug pricing. Issue regarding plasma-based therapies.
HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (5)
MARY BETH SAVARY TAYLOR
GREG D'ANGELO
BRETT BAKER
RACHEL JONES HENSLER